Related Experiment Videos
Management of raised intracranial pressure
1Academic Neurosurgical Unit, Addenbrooke's Hospital, Cambridge, UK.
Abstract:
This review has been written at an unfortunate time. Novel questions are being asked of the old therapies and there is an abundance of new strategies both to lower ICP and protect the brain against cerebral ischaemia. In the United Kingdom, the problem is to ensure that appropriate patients continue to be referred to centres where clinical trials of high quality can be undertaken. One of the success stories of the past decade has been the decline in the number of road accidents as a result of seat belt legislation, improvements in car design and the drink/driving laws. Hence, fortunately there are fewer patients with head injuries to treat and it is even more important that patients are appropriately referred if studies to assess efficacy of the new strategies are not to be thwarted. The nihilistic concept that intensive investigation with ICP monitoring for patients with diffuse head injury or brain swelling following evacuation of a haematoma or a contusion has no proven beneficial effect on outcome, requires revision. A cocktail of therapies may be required that can be created only when patients are monitored in sufficient detail to reveal the mechanisms underlying their individual ICP problem. Ethical problems may arise over how aggressively therapy for intracranial hypertension should be pursued and for how long. There has always been the concern that cranial decompression or prolonged barbiturate coma may preserve patients but with unacceptably severe disability. Some patients may be salvaged from herniating with massive cerebral infarction with the use of osmotherapy but is the outcome acceptable? Similar considerations apply to some children with metabolic encephalopathies. Where such considerations have been scrutinised in patients with severe head injury, the whole spectrum of outcomes appears to be shifted so that the number of severe disabilities and persistent vegetative states are not increased. However, it is important to be sensitive to such issues based on experience of the particular cause of raised intracranial pressure in a given age group.
Insights
New strategies to lower intracranial pressure (ICP) and protect the brain require careful patient selection for clinical trials. Revising the nihilistic approach to ICP monitoring can optimize treatment for diffuse head injuries and brain swelling.
Area of Science:
- Neuroscience
- Critical Care Medicine
- Neurology
Background:
- Declining head injury rates due to safety measures necessitate focused research.
- Existing approaches to managing intracranial pressure (ICP) and cerebral ischemia are being re-evaluated.
- There is a growing need for high-quality clinical trials to assess novel therapeutic strategies.
Purpose of the Study:
- To review current strategies for lowering ICP and protecting the brain against cerebral ischemia.
- To emphasize the importance of appropriate patient referral for clinical trials.
- To challenge the notion that ICP monitoring has no proven benefit in certain head injury cases.
Main Methods:
- Review of existing literature on intracranial pressure management and cerebral ischemia.
- Discussion of novel therapeutic strategies and their potential efficacy.
- Analysis of ethical considerations in aggressive ICP management and patient outcomes.
Main Results:
- A shift towards personalized, multi-faceted therapeutic approaches based on detailed ICP monitoring is suggested.
- Evidence indicates that aggressive ICP management may not increase severe disabilities or vegetative states.
- Careful consideration of specific causes and age groups is crucial for ethical and effective treatment.
Conclusions:
- ICP monitoring and tailored therapies are essential for optimizing outcomes in patients with raised ICP.
- Effective management requires a nuanced approach, balancing aggressive treatment with ethical considerations and patient prognosis.
- Continued research and high-quality clinical trials are vital for advancing the treatment of severe head injuries and brain swelling.